TNDM Tandem Diabetes Care
- 30.930
- -0.820-2.58%
- 30.500
- -0.430-1.39%
Tandem Diabetes Care News
Tandem Diabetes Care Analyst Ratings
Tandem Diabetes Care Analyst Ratings
Tandem Diabetes Care Analyst Ratings
Tandem Diabetes Care (TNDM) Gets a Buy From Lake Street
Craig-Hallum Sticks to Its Buy Rating for Tandem Diabetes Care (TNDM)
Tandem Diabetes Care Holds Steady: A Cautious Outlook Amidst Growth and Competitive Uncertainty
Analysts Are Bullish on Top Healthcare Stocks: Intellia Therapeutics (NTLA), Tandem Diabetes Care (TNDM)
Analysts Offer Insights on Healthcare Companies: Savara (SVRA), Harmony Biosciences Holdings (HRMY) and Tandem Diabetes Care (TNDM)
Piper Sandler Reaffirms Their Buy Rating on Tandem Diabetes Care (TNDM)
Tandem Diabetes Care: Steady Growth Prospects and Hold Rating Amid Market Challenges
Analysts Offer Insights on Healthcare Companies: Exact Sciences (EXAS) and Tandem Diabetes Care (TNDM)
Lake Street Sticks to Their Buy Rating for Tandem Diabetes Care (TNDM)
Analysts Are Bullish on These Healthcare Stocks: LifeMD (LFMD), Tandem Diabetes Care (TNDM)
Hold Rating on Tandem Diabetes Care Amidst Competitive Market and Mobi Launch Uncertainties
Tandem Diabetes Care Analyst Ratings
UBS Raises Tandem Diabetes Care Price Target to $28 From $18, Maintains Neutral Rating
Tandem Diabetes Care (TNDM) Gets a Buy From Craig-Hallum
Analysts Conflicted on These Healthcare Names: Adaptimmune Therapeutics (ADAP) and Tandem Diabetes Care (TNDM)
Analyst Maintains Hold Rating on Tandem Diabetes Care Amid Lowered Revenue Guidance and Market Challenges
Tandem Diabetes Care Analyst Ratings
Analysis
Price Target
No Data
